Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb in a cancer immunotherapy alliance that seeks to challenge ...
The Open VSX registry rotated access tokens after they were accidentally leaked by developers in public repositories and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback